Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Trelagliptin (SYR-472, Zafatek), Novel Once-Weekly Treatment for Type 2 Diabetes, Inhibits Dipeptidyl Peptidase-4 (DPP-4) via a Non-Covalent Mechanism

Fig 6

Comparison of x-ray crystal structures of inhibitors bound to DPP-4.

Comparison of x-ray crystal structure of inhibitors bound to DPP-4 for alogliptin (left panel) and trelagliptin (right panel).

Fig 6

doi: https://doi.org/10.1371/journal.pone.0157509.g006